Cinzia Bertolin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Cinzia Bertolin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Leonardo Salviati
Department of Women's and Children's Health University of Padova Padova Italy
3 shared publications - Francesca Pistonesi
Neurodegenerative Disease Unit, Department of Neuroscience, Padova Neuroscience Center (PNC), University of Padua, Padova, Italy
2 shared publications - Miryam Carecchio
Department of Neuroscience, University of Padua, Padua, Italy
2 shared publications - Altin Adraman
Neuroradiology Unit, Department of Neuroscience, University of Padua, Padova, Italy
1 shared publication - Andrea Trevisan
University of Padua
1 shared publication - Angelo Antonini
Parkinson and Movement Disorders Unit, Centre for Rare Neurological Diseases (ERN-RND), Department of Neuroscience, University of Padua, Padua, Italy
1 shared publication
Latest Publications
- Open Access
Cutaneous Manifestations of Variegate Porphyria in a Young Entertainer: Possible Occupational and Environmental Triggers
Background and Clinical Significance: Variegate porphyria (VP) is a rare hepatic porphyria caused by a partial deficiency in protoporphyrinogen oxidase (PPOX), the penultimate enzyme in the heme biosynthesis pathway. This enzymatic defect leads to the accumulation of porphyrins and their precursors, resulting in a broad spectrum of clinical manifestations. The disease may present with cutaneous symptoms, typically chronic skin blistering, and/or acute episodes characterized by severe neurovisceral symptoms. Case presentation: We present the case of 24-year-old woman with VP who began working as an entertainer at a tourist resort in Turkey. Her role involves intense, prolonged shifts, often with significant sun exposure and considerable physical and psychological stress. After several months of work, the patient developed severe hand lesions, significantly influencing both her job performance and daily life, leading to pain, discomfort, and general malaise. The village doctor prescribed a topical treatment with corticosteroids and antibiotics, without an improvement in dermatological lesions. Conclusions: The case presented has two important implications: (1) it is the first case of a subject affected by a rare disease such as VP exacerbated by occupational exposure and (2) it suggests that hemin, routinely used to treat acute attacks, may also have a therapeutic benefit for the cutaneous manifestations of VP.
Open AccessCutaneous Manifestations of Variegate Porphyria in a Young Entertainer: Possible Occupational and Environmental Triggers
Background and Clinical Significance: Variegate porphyria (VP) is a rare hepatic porphyria caused by a partial deficiency in protoporphyrinogen oxidase (PPOX), the penultimate enzyme in the heme biosynthesis pathway. This enzymatic defect leads to the accumulation of porphyrins and their precursors, resulting in a broad spectrum of clinical manifestations. The disease may present with cutaneous symptoms, typically chronic skin blistering, and/or acute episodes characterized by severe neurovisceral symptoms. Case presentation: We present the case of 24-year-old woman with VP who began working as an entertainer at a tourist resort in Turkey. Her role involves intense, prolonged shifts, often with significant sun exposure and considerable physical and psychological stress. After several months of work, the patient developed severe hand lesions, significantly influencing both her job performance and daily life, leading to pain, discomfort, and general malaise. The village doctor prescribed a topical treatment with corticosteroids and antibiotics, without an improvement in dermatological lesions. Conclusions: The case presented has two important implications: (1) it is the first case of a subject affected by a rare disease such as VP exacerbated by occupational exposure and (2) it suggests that hemin, routinely used to treat acute attacks, may also have a therapeutic benefit for the cutaneous manifestations of VP.
- Open Access
- 11 August 2026
- Published by Springer Nature in Neuroradiology
- p. 1-14
Cerebellar and brainstem MRI alterations in primary brain calcification
Purpose: Primary Brain Calcification (PBC) is a neurodegenerative disorder with marked genetic, radiological, and clinical heterogeneity. Infratentorial changes are largely unknown, and MRI role is still underinvestigated. Methods: Fifty PBC patients underwent brain 3T-MRI (3D-FLAIR, 3D-T1, 3D-T2, SWI), genetic, and clinical-neuropsychological evaluation. 50 matched controls were enrolled. Qualitative signal abnormalities and quantitative measures of cerebellar and brainstem atrophy were correlated with genetic and clinical data. Results: PBC patients frequently showed abnormal cerebellar (86%) and brainstem (46%) findings. Compared to controls, patients showed more frequently brainstem vascular involvement, cerebellar and brainstem atrophy, T1 and SWI alterations in dentate nuclei and cerebellar cortex, and SWI changes in medullary corpora and middle cerebellar peduncles, with a dentate-to-peduncular gradient. Cerebellar and brainstem atrophy were associated with cerebellar cortex, medulla oblongata nuclei and middle cerebellar peduncles SWI-abnormalities, red nuclei T1-hyperintensity, and dentate nucleus hila FLAIR-hyperintensity. Voxel-based-morphometry demonstrated superior cerebellar peduncles decussation, red nuclei, and subthalamic nuclei atrophy; region-of-interest-based analysis showed cerebellar, pontine, and midbrain atrophy. Definite PBC showed a higher burden of qualitative MRI abnormalities than probable PBC and controls. Voxel-based-morphometry confirmed more extensive atrophy in definite PBC vs. controls, probable PBC did not differ from other subgroups. At multivariate analysis, brainstem atrophy was an independent predictor of freezing ( p = 0.03) and oculomotor dysfunction ( p = 0.01), brainstem vascular involvement of falls ( p = 0.003), cerebellar atrophy of dysarthria ( p = 0.002) and cerebellar signs ( p = 0.04). Conclusions: Infratentorial qualitative and quantitative MRI abnormalities are common and clinically relevant in PBC, and identify neurodegenerative changes that improve our understanding of its clinical heterogeneity.
- 11 August 2026
- Published by Springer Nature in Neuroradiology
- p. 1-14
Open AccessCerebellar and brainstem MRI alterations in primary brain calcification
Purpose: Primary Brain Calcification (PBC) is a neurodegenerative disorder with marked genetic, radiological, and clinical heterogeneity. Infratentorial changes are largely unknown, and MRI role is still underinvestigated. Methods: Fifty PBC patients underwent brain 3T-MRI (3D-FLAIR, 3D-T1, 3D-T2, SWI), genetic, and clinical-neuropsychological evaluation. 50 matched controls were enrolled. Qualitative signal abnormalities and quantitative measures of cerebellar and brainstem atrophy were correlated with genetic and clinical data. Results: PBC patients frequently showed abnormal cerebellar (86%) and brainstem (46%) findings. Compared to controls, patients showed more frequently brainstem vascular involvement, cerebellar and brainstem atrophy, T1 and SWI alterations in dentate nuclei and cerebellar cortex, and SWI changes in medullary corpora and middle cerebellar peduncles, with a dentate-to-peduncular gradient. Cerebellar and brainstem atrophy were associated with cerebellar cortex, medulla oblongata nuclei and middle cerebellar peduncles SWI-abnormalities, red nuclei T1-hyperintensity, and dentate nucleus hila FLAIR-hyperintensity. Voxel-based-morphometry demonstrated superior cerebellar peduncles decussation, red nuclei, and subthalamic nuclei atrophy; region-of-interest-based analysis showed cerebellar, pontine, and midbrain atrophy. Definite PBC showed a higher burden of qualitative MRI abnormalities than probable PBC and controls. Voxel-based-morphometry confirmed more extensive atrophy in definite PBC vs. controls, probable PBC did not differ from other subgroups. At multivariate analysis, brainstem atrophy was an independent predictor of freezing ( p = 0.03) and oculomotor dysfunction ( p = 0.01), brainstem vascular involvement of falls ( p = 0.003), cerebellar atrophy of dysarthria ( p = 0.002) and cerebellar signs ( p = 0.04). Conclusions: Infratentorial qualitative and quantitative MRI abnormalities are common and clinically relevant in PBC, and identify neurodegenerative changes that improve our understanding of its clinical heterogeneity.
- Open Access
- 30 June 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (13) , 3873
Non-Motor Symptoms in Primary Familial Brain Calcification
Background/Objectives: Primary Familial Brain Calcification is a rare neurodegenerative disorder of adulthood characterized by calcium deposition in the basal ganglia and other brain areas; the main clinical manifestations include movement disorders, mainly parkinsonism. Non-motor symptoms are not well defined in PFBC. This work aims at defining the burden of non-motor symptoms in PFBC. Methods: A clinical, genetic and neuropsychological evaluation of a cohort of PFBC patients, COMPASS-31 scale administration. Results: A total of 50 PFBC patients were recruited; in 25, the genetic test was negative; 10 carried mutations in SLC20A2 gene, 8 in MYORG, 3 in PDGFB, 1 in PDGFRB, 2 in JAM2 (single mutations), and one test is still ongoing. The main motor manifestation was parkinsonism. Headache was reported in 26% of subjects (especially in PDGFB mutation carriers), anxiety or depression in 62%, psychosis or hallucinations in 10–12%, sleep disturbances in 34%; 14% of patients reported hyposmia, 32% constipation, and 34% urinary disturbances. A neuropsychological assessment revealed cognitive involvement in 56% (sparing memory functions, to some extent). The COMPASS-31 mean score was 20.6, with higher sub-scores in orthostatic intolerance and gastrointestinal problems. MYORG patients and subjects with cognitive decline tended to have higher scores and bladder involvement compared to other groups. Conclusions: The presence of non-motor symptoms is frequent in PFBC and should be systematically assessed to better meet patients’ needs.
- 30 June 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (13) , 3873
Open AccessNon-Motor Symptoms in Primary Familial Brain Calcification
Background/Objectives: Primary Familial Brain Calcification is a rare neurodegenerative disorder of adulthood characterized by calcium deposition in the basal ganglia and other brain areas; the main clinical manifestations include movement disorders, mainly parkinsonism. Non-motor symptoms are not well defined in PFBC. This work aims at defining the burden of non-motor symptoms in PFBC. Methods: A clinical, genetic and neuropsychological evaluation of a cohort of PFBC patients, COMPASS-31 scale administration. Results: A total of 50 PFBC patients were recruited; in 25, the genetic test was negative; 10 carried mutations in SLC20A2 gene, 8 in MYORG, 3 in PDGFB, 1 in PDGFRB, 2 in JAM2 (single mutations), and one test is still ongoing. The main motor manifestation was parkinsonism. Headache was reported in 26% of subjects (especially in PDGFB mutation carriers), anxiety or depression in 62%, psychosis or hallucinations in 10–12%, sleep disturbances in 34%; 14% of patients reported hyposmia, 32% constipation, and 34% urinary disturbances. A neuropsychological assessment revealed cognitive involvement in 56% (sparing memory functions, to some extent). The COMPASS-31 mean score was 20.6, with higher sub-scores in orthostatic intolerance and gastrointestinal problems. MYORG patients and subjects with cognitive decline tended to have higher scores and bladder involvement compared to other groups. Conclusions: The presence of non-motor symptoms is frequent in PFBC and should be systematically assessed to better meet patients’ needs.